Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunosuppressive effects of NK-026680 useful for acute GVHD

Jan. 5, 2006

IDM Pharma completes sale of non-core assets to Pharmexa

Jan. 5, 2006

Pharming files for GRAS notification for human lactoferrin

Jan. 3, 2006

Astellas submits NDA for FK-506 modified release formulation

Dec. 28, 2005

FTC clearance for Roche's licensing of BCX-4208

Dec. 27, 2005

Tanabe Seiyaku launches Mearubik combined vaccine for measles and rubella

Dec. 23, 2005

Orphan drug designation for Prochymal in GVHD

Dec. 23, 2005

PKC inhibitors for transplant rejection claimed in Novartis patent

Dec. 22, 2005

FDA Advisory Committee vote positively on Rotateq

Dec. 19, 2005

Biothera begins phase I trial for Imprime PGG

Dec. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...